SUMMARY
Javier L. Munoz, M.D., M.B.A., is a hematologist-oncologist at Mayo Clinic who specializes in treating and researching lymphoma. Dr. Munoz is director of the Lymphoma Group at Mayo Clinic in Arizona and is a member of the CAR-T Cell Therapy Program. He also is the associate medical director of the Cancer Clinical Research Office of the Mayo Clinic Comprehensive Cancer Center.
Dr. Munoz has been a principal investigator in multiple cutting-edge lymphoma trials, including studies on immunotherapy and CAR-T cells. Dr. Munoz has published his research findings in internationally renowned journals, including The New England Journal of Medicine, Nature Reviews, Blood and JAMA.
Focus areas
- Lymphoma and immunotherapy. Using insights gained from knowledge about the immunologic, molecular and genetic events that lead to the development of lymphoma, Dr. Munoz and his team participate in key clinical trials to advance the science for lymphoma.
- CAR-T cell therapy. Dr. Munoz has extensive experience conducting leading-edge research in cellular therapy that has dramatically changed the therapeutic landscape for lymphoma.
- Clinical trials. Dr. Munoz is an active investigator in clinical trials designed to evaluate new medicines or therapeutic approaches for lymphoma. He has served as a principal investigator or co-investigator in many national and international clinical trials.
Significance to patient care
Dr. Munoz's research efforts have led to a better understanding of lymphoma and related lymphoproliferative disorders. His work also has unlocked novel therapeutic options to treat cancer, including several medicines approved by the U.S. Food and Drug Administration (FDA). His goal is to continue to develop nonchemotherapy agents through clinical trials. Dr. Munoz is strongly focused on positively impacting care and bringing forward the best novel therapies.
Professional highlights
- American Society of Clinical Oncology:
- Member, 2008-present.
- Mentee, Virtual Mentoring Program, 2018.
- Mentor, Diversity Mentoring Program, 2017.
- American Society of Hematology:
- Member, 2008-present.
- Health Volunteers Overseas, 2018.
- Practice Partnership, 2017.
- Advocacy Leadership Institute, 2015.
- Editorial board member, JCO Global Oncology, 2015-2018.
- Fellow, American College of Physicians (FACP), 2013-present.